Background: The zebrafish (Danio rerio) has recently been shown to be an ideal
| INTRODUCTION
Osteoporosis (OP) is a degenerative bone disease characterized by decreased bone mass, microstructural bone degradation, and increased fracture risk. The pathogenesis of OP is associated with an imbalance in bone metabolism, including disruptions to bone formation and bone resorption processes, regulated by osteoclasts and osteoblasts, respectively. OP takes hold when the rate of bone formation is lower than that of bone resorption. Drugs for treating OP include bone resorption inhibitors and bone formation enhancers.
Bone resorption inhibitors represent the largest drug class and include bisphosphonates, hormone replacement therapy (HRT), selective estrogen receptor modulators (SERMs), calcitonin, and rank ligand inhibitors. 1 These treatments increase bone mineral density (BMD) through the inhibition of bone resorption. Bone formation enhancers directly stimulate bone formation, and promote the production of collagen and bone matrix by osteoblasts. Many traditional
Chinese medicines or compounds have been shown to have some efficacy in these processes, in vitro studies and live rats, including the so-called Liuwei Dihuang, 2 epimedium, 3 salvia miltiorrhizae, 4 and fructus cnidii. TGF-b, and Hedgehog signaling. 6 Broadly similar to mammals, bone formation in lower vertebrates also features endochondral and intramembranous ossification controlled by a series of transcription factors and hormones. Key regulators involved in zebrafish bone formation include osterix, runx2a/b, col10a1, and osteonectin, 7 which are homologous to human bone formation regulators. Overall, these common developmental features provide a rationale for using zebrafish as a research model for diseases of the maturing skeleton, and, arguably, of the adult skeleton. [8] [9] [10] Transgenic technology, which uses reporter genes inserted downstream of a tissue-specific promoter, can be used to produce fluorescence in specific organs. This technology has been used in zebrafish to enable the studies of gene function at the molecular level as well as for drug screening. The transgenic zebrafish line Tg(ola.sp7:nlsGFP) that expresses enhanced green fluorescent protein (eGFP) in bone has already been used by researchers to study the development of axial skeleton.
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Patients treated with various glucocorticoids sometimes develop OP as a side effect. 12, 13 In most vertebrates, including mammals, the glucocorticoid system is highly conserved. Similar symptoms can be induced in mice. 14 Glucocorticoids have also been used in zebrafish to induce OP-like symptoms and create a model of OP. 15, 16 Chemical staining using calcein, quercetin, and alizarin red is a much-used method in bone research. 17 Staining using alizarin red which can chelate with calcium ions is the most commonly used visualization method for bone mineralization in zebrafish. 8, 15, 16, 18 
| Generating transgenic zebrafish using gateway transposon system
Tg(ola.sp7:nlsGFP) transgenic zebrafish were generated using the Tol2 transposon system as previously described. 20 pDestTol2CG2-osterix-nlseGFP-pA plasmid was kindly provided by the laboratory of Schulte-Merker. Adult founder fish were identified by out-crossing them to wild-type zebrafish and screening the F1 generation for eGFP-expressing embryos. Homozygous embryos laid from the same pair of adult fishes expressing strong eGFP were used in the same set of experiment in this study.
| Zebrafish osteoporosis model induction
Wild-type or transgenic larvae at 4 days postfertilization (dpf) were raised in 12-well plates. N-phenylthiourea (PTU, Sigma, USA) was added to the embryo water to prevent pigmentation. For GIOP model establishment, embryos were exposed to dexamethasone derived from epimedium (FE, purity > 90%, Tianyuan-BioPharm, China) with series concentrations of 1.0, 0.5, and 0.1 lg/mL were mixed with 10 lM Dex to select the best effective concentration.
DMSO (1:1000) and pure egg water groups were set as controls.
Half the volume of the embryo water was refreshed daily (with Dex and/or FE). All trials were ended on the fifth day and 8 dpf fish were collected for bone mineralization analysis. n = 18 embryos per group. 
|

| Imaging and evaluation of bone mineralization
Zebrafish larvae were fixed in 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS). For wild-type fish staining, zebrafish larvae were stained with alizarin red as described previously. 21 Embryos were embedded and imaged using a M205 FA stereomicroscope (Leica, Germany). The gain, saturation, exposure, and lighting levels were identical for each imaging procedure. Tg(ola.sp7:nlsGFP) transgenic zebrafish was imaged with a laser scanning confocal microscope (LSCM) (Leica TCS SP5 II, Germany) for 3D reconstruction. During all the imaging processes of all the groups of fish, the LSCM imaging parameters were set identically. The pinhole was set as 1 AU and digital gain was set as 1.0; Both the master gain and digital offset were set as the lowest to avoid overexposure. The optimized sectioning depth was adopted for the Z-Stack and internal depth setting. Bone mineralization was evaluated from 3D reconstructed images and quantified using Image-Pro software (Image-Pro Plus 6.0, USA). During the measurement of density and IOD, the eyedropper tool was used to repeatedly and precisely select the region of interest (ROI) until all the ROI are chosen. For wild-type fish, the alizarin red-stained area (excluding the otolith region) was measured as previously described. 9 For transgenic fish, fluorescent images were first inverted to grayscale images. Then, the fluorescent area and IOD, representing the extent of mineralization and BMD, respectively, were measured in the same way as the alizarin redstained embryos. For the calculation of the signal intensity, the "measurement data" and "statistics" function were adopted to make T test of IOD results. n = 18 embryos per group.
| Statistics
A one-way ANOVA with Tukey's post hoc tests were used to determine differences between groups in various experiments. The differences between two groups were analyzed by Student's t tests.
Differences were considered significant when P values were less than .05. Data are presented as mean AE SD. During this period, the structure and morphology of cephalic bones undergo no distinguishable changes (data not shown). There were no significant variations in either both bone mass or BMD, which was F I G U R E 2 Cephalic bone mass and BMD changes in Tg(ola.sp7:nlsGFP) zebrafish during 4-8 dpf developmental stages. Bone mass and bone mineral density (BMD) were evaluated by measuring GFP area and integrated optical density. There is no significant difference among during these stages. Data are presented as means AE SD. n = 18 fish for each group (A) (B)
Comparison of GFP-labeled cephalic bones in Tg(ola.sp7:nlsGFP) zebrafish to alizarin red-stained cephalic bones at 8 dpf. (A), Alizarin red stains mineralized bones in zebrafish head region, including cleithrum, opercle, branchiostegal rays, mandible, and notochord. (B), 3D-reconstructed confocal image of Tg(ola.sp7:nlsGFP) zebrafish larvae. In comparison with alizarin red-stained fish, eGFP is not expressed in the notochord of transgenic fish. CT, cleithrum; BR, branchiostegal rays; MD, mandible; NC, notochord
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F I G U R E 4 Morphologies of zebrafish larvae after Dex induction or FE treatment. In blank and DMSO-treated control groups, zebrafish display a straight fish body (A, B). In Dex-induced OP models, the larvae show a bent body and a curve at the link point of the head and trunk region as depicted by the red dash lines. This impairment is exacerbated by the increase in the Dex concentration from 5 lM to 20 lM (C-E).
(F), 1 lg/mL FE treatment rescues the impaired morphology observed in OP-like fish reflected in the eGFP fluorescent area and IOD, respectively, during these developmental stages (Figure 2) . Therefore, zebrafish larvae from 4 to 8 dpf were used in this study.
Alizarin red, which chelates with calcium ions, labels mineralized bones and is the most common method of studying bone mineralization. When comparing the early stage bone structures resultant from these two methods, there was a distinct difference, especially in the anterior notochord region which was clearly marked by alizarin red staining but remained unmarked in transgenic fish in zebrafish larvae at 8 dpf (Figure 3 ).
To induce OP-like symptoms, different concentrations of Dex were administered to 4 dpf zebrafish larvae. Morphologically, there was no significant difference between the blank (solely water-incubated embryos) and DMSO-incubated zebrafish larvae.
At 8 dpf, zebrafish treated with 5 lM Dex displayed a slight curve in the linked region of the brain and trunk when compared with nontreated or DMSO-treated controls ( Figure 4A -C).
This phenotype was exacerbated by increasing concentrations of
Dex from 10 to 20 lM ( Figure 4D,E) . When comparing the cephalic bone images by morphometry, all treated embryos presented similar structures within alizarin red-stained groups and Tg(ola.sp7:nlsGFP) groups, respectively ( Figure 5A,B) . However, the signal strength of Dex-treated larvae displayed decreasing trends in both alizarin red staining and green fluorescence (Figure 5A,B) . Within both groups, larvae exposed to 5 lM Dex showed significantly decreased mineralized areas compared with DMSO-treated ones (P < .05 or P < .01). Increasing the concentration to either 10 or 20 lM further enhanced this difference F I G U R E 5 Dex induces OP-like symptom in both wild-type and Tg(ola.sp7:nlsGFP) zebrafish. (A), Dex-treated larvae were stained by alizarin red. The stained area show the level of bone mineralization which is decreased in a dose-dependent manner of Dex concentration from 0 to 20 lM (D). (B), 3D-reconstructed confocal images of Dex-treated Tg(ola.sp7:nlsGFP) zebrafish. Bone mass and density are reflected by GFP area and integrated optical density, which also presented a dose-dependent manner of Dex concentration from 0 to 20 lM (E, F). Images in white frames are 59 magnifications relative to the red insets, where osteoblasts are visible (white arrow). Data are presented as means AE SD; *P < .05; **P < .01; ***P < .001; n = 18 fish in each group; scale bar, 100 lm (P < .001, Figure 5A -F). The above results indicated that the evaluation method using eGFP area and IOD as parameters can reflect the level of bone mass loss. The results were consistent with those from traditional alizarin red staining, suggesting a successful generation of zebrafish GIOP model using Tg(ola.sp7:
nlsGFP) line ( Figure 5D-F) .
F I G U R E 6 FE treatment promotes zebrafish bone mass and growth. (A, B) , Bone mass and density were calculated by measuring GFP area and integrated optical density. FE can significantly promote the bone mass of zebrafish cephalic bones compared to DMSO-treated controls. Data are presented as means AE SD. *P < .05; n = 18 fish for each group F I G U R E 7 FE rescues OP-like symptom induced by Dex. (A), Alizarin red-stained zebrafish head regions of FE-treated larvae. 1 lg/mL FEadded zebrafish totally recovers the stained signal strength in comparison with GIOP model (**P < .01) (D). (B), 3D-reconstructed confocal images of FE-treated Tg(ola.sp7:nlsGFP) zebrafish head regions. Bone mass and bone mineral density (BMD) evaluated by fluorescent area and IOD reflect a rescued effect on 1 lg/mL FE-treated OP-like zebrafish (**P < .01) (E, F). Data are presented as means AE SD; **P < .01; ***P < .001; n = 18 fish in each group; scale bar, 100 lm
| Rescue from GIOP using flavonoid treatment
Based on the successful establishment of the GIOP model, we next examined the clinical relevance of this model by treating with flavonoid, which was extracted from the traditional Chinese medicine epimedium (FE) and which has been reported to exert anti-OP effects in rat studies. 3 Primary analysis of 1 lg/mL FE effects on zebrafish bone growth indicated that FE stimulation could increase the bone mass, as reflected in both the fluorescent area and IOD (both P < .05, Figure 6 ). To investigate the restorative effect of FE on the GIOP model, different concentrations of FE were mixed with 10 lM Dex and tested on zebrafish larvae from 4 to 8 dpf. As a result, 1 lg/mL FE-added mixture rescued zebrafish larvae from a and osteopontin, whereas tracp expression was significantly upregulated (P < .01, Figure 8 ). Compared with the GIOP group, FE treatment up-regulated the expression of osterix, osteocalcin, and osteopontin (P < .05), but had no effect on tracp expression (P > .05).
Moreover, consistent with the eGFP protein expression variations in osteoblasts, the expression level of egfp mRNA was also downregulated in GIOP models, and upregulated in FE-rescued OP Tg(ola.sp7: nlsGFP) fish, respectively.
| DISCUSSION
In this study, we used cortical bone transgenic zebrafish Tg(ola.sp7: nlsGFP), which express eGFP in osteoblasts, to establish a GIOP model. In this model, mineralized bone area and density were directly evaluated by measuring the area and intensity of eGFP signals in osteoblasts. After Dex administration, the variations of bone loss and BMD reduction observed in Tg(ola.sp7:nlsGFP) images were consistent with the traditional chemical staining methods using alizarin red. However, when comparing the early stage bone structures resultant from these two methods, there was a distinct difference, especially in the anterior notochord region. The notochords of 8 dpf zebrafish were clearly marked by alizarin red staining but remained unmarked in transgenic fish (Figure 3) . Alizarin red, which chelates with calcium ions, labels mineralized bones and is the most common method of studying bone mineralization. In Tg(ola.sp7:nlsGFP) zebrafish, expression of eGFP was driven by the promoter of osterix, an osteoblast-specific gene. 22 Therefore, eGFP only labels osteoblast-
Gene expression alterations in GIOP and FE-treated zebrafish. Osteoblast-related genes osterix, osteocalcin, and osteopontin are significantly downregulated by 10 lM Dex treatment, and upregulated again in FE-added zebrafish. Osteoclast-related tracp is upregulated by Dex induction, whereas the FE treatment is unable to downregulate its expression. Data are presented as means AE SD. *P < .05; **P < .01; ***P < .001; n = 4 repeats composed bones. At the early stage of zebrafish development, the notochord is more like a cartilage, and has no involvement with osteoblasts. 23 Hence, no eGFP was observed in notochords.
As a traditional Chinese medicine to reinforce kidney and bone strength, FE has been reported to exert therapeutic effects on mice in OP models. 3 Quantified results of bone mass and mineral density from both alizarin red-stained and transgenic Tg(ola. 
